Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid

Organs-on-chips at the frontiers of drug discovery

Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185 · see citing works

Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease

Bell, C. C., Hendriks, D. F. G., Moro, S. M. L., Ellis, E., Walsh, J., Renblom, A., Fredriksson Puigvert, L., Dankers, A. C. A., Jacobs, F., Snoeys, J., et al. (2016) · Scientific Reports · doi:10.1038/srep25187 · Cited by 739 · see citing works

Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform

Skardal, A., Murphy, S. V., Devarasetty, M., Mead, I., Kang, H.-W., Seol, Y.-J., Shrike Zhang, Y., Shin, S.-R., Zhao, L., Aleman, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08879-x · Cited by 623 · see citing works

Worldwide Distribution of Cytochrome P450 Alleles: A Meta‐analysis of Population‐scale Sequencing Projects

Zhou, Y., Ingelman‐Sundberg, M., & Lauschke, V. M. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.690 · Cited by 592 · see citing works

Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2

Raucy, J. L., Lasker, J. M., Lieber, C. S., & Black, M. (1989) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(89)90278-6 · Cited by 478 · see citing works

Managing the challenge of chemically reactive metabolites in drug development

Park, B. K., Boobis, A. R., Clarke, S. E., Goldring, C. E., Jones, D., Kenna, J. G., Lambert, C., Laverty, H., Naisbitt, D. J., Nelson, S. D., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3408 · Cited by 466 · see citing works

Acetaminophen (APAP) hepatotoxicity—Isn’t it time for APAP to go away?

Lee, W. M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.005 · Cited by 445 · see citing works

PharmGKB summary

Mazaleuskaya, L. L., Sangkuhl, K., Thorn, C. F., FitzGerald, G. A., Altman, R. B., & Klein, T. E. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000150 · Cited by 381 · see citing works

Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury

Proctor, W. R., Foster, A. J., Vogt, J., Summers, C., Middleton, B., Pilling, M. A., Shienson, D., Kijanska, M., Ströbel, S., Kelm, J. M., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2002-1 · Cited by 328 · cited 3× · see citing works

Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study

Bell, C. C., Dankers, A. C. A., Lauschke, V. M., Sison-Young, R., Jenkins, R., Rowe, C., Goldring, C. E., Park, K., Regan, S. L., Walker, T., et al. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfx289 · Cited by 327 · see citing works

Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes

Laine, J., Auriola, S. O. K., Pasanen, M., & Juvonen, R. O. (2009) · Xenobiotica · doi:10.1080/00498250802512830 · Cited by 258 · see citing works

Mimicking liver sinusoidal structures and functions using a 3D-configured microfluidic chip

Du, Y., Li, N., Yang, H., Luo, C., Gong, Y., Tong, C., Gao, Y., Lü, S., & Long, M. (2017) · Lab on a Chip · doi:10.1039/c6lc01374k · Cited by 241 · see citing works

Oxidation of Acetaminophen to Its Toxic Quinone Imine and Nontoxic Catechol Metabolites by Baculovirus-Expressed and Purified Human Cytochromes P450 2E1 and 2A6

Chen, W., Koenigs, L. L., Thompson, S. J., Peter, R. M., Rettie, A. E., Trager, W. F., & Nelson, S. D. (1998) · Chemical Research in Toxicology · doi:10.1021/tx9701687 · Cited by 226 · see citing works

Evaluation of Cryopreserved Human Hepatocytes as an Alternative in Vitro System to Microsomes for the Prediction of Metabolic Clearance

Brown, H. S., Griffin, M., & Houston, J. B. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.011569 · Cited by 212 · see citing works

Prediction of Drug-Induced Hepatotoxicity Using Long-Term Stable Primary Hepatic 3D Spheroid Cultures in Chemically Defined Conditions

Vorrink, S. U., Zhou, Y., Ingelman-Sundberg, M., & Lauschke, V. M. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy058 · Cited by 187 · see citing works

Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long-term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics

Vorrink, S. U., Ullah, S., Schmidt, S., Nandania, J., Velagapudi, V., Beck, O., Ingelman‐Sundberg, M., & Lauschke, V. M. (2017) · The FASEB Journal · doi:10.1096/fj.201601375r · Cited by 172 · see citing works

Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts.

Lewis, W., Levine, E. S., Griniuvienė, B., Tankersley, K. O., Colacino, J. M., Sommadossi, J., Watanabe, K. A., & Perrino, F. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3592 · Cited by 169 · see citing works

In vitro platforms for evaluating liver toxicity

Bale, S. S., Vernetti, L. A., Senutovitch, N., Jindal, R., Hegde, M., Gough, A., McCarty, W. J., Bakan, A., Bhushan, A., Shun, T. Y., et al. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214531872 · Cited by 156 · see citing works

The covalent binding of acetaminophen to protein. Evidence for cysteine residues as major sites of arylation in vitro

Streeter, A. J., Dahlin, D. C., Nelson, S. D., & Baillie, T. A. (1984) · Chemico-Biological Interactions · doi:10.1016/0009-2797(84)90145-5 · Cited by 151 · see citing works

Control of oxygen tension recapitulates zone-specific functions in human liver microphysiology systems

Lee-Montiel, F. T., George, S. M., Gough, A., Sharma, A. D., Wu, J., DeBiasio, R., Vernetti, L. A., & Taylor, D. L. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217703978 · Cited by 141 · see citing works

Inter‐subject and ethnic differences in paracetamol metabolism.

Critchley, J., Nimmo, G. R., Gregson, C., Woolhouse, N. M., & Prescott, L. (1986) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1986.tb02953.x · Cited by 140 · see citing works

A glass-based, continuously zonated and vascularized human liver acinus microphysiological system (vLAMPS) designed for experimental modeling of diseases and ADME/TOX

Li, X., George, S. M., Vernetti, L. A., Gough, A., & Taylor, D. L. (2018) · Lab on a Chip · doi:10.1039/c8lc00418h · Cited by 138 · see citing works

Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery

Ewart, L. C., Dehne, E., Fabre, K. M., Gibbs, S., Hickman, J. J., Hornberg, E., Ingelman‐Sundberg, M., Jang, K., Jones, D. R., Lauschke, V. M., et al. (2017) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052722 · Cited by 130 · see citing works

Quantitative Assessment of Population Variability in Hepatic Drug Metabolism Using a Perfused Three-Dimensional Human Liver Microphysiological System

Tsamandouras, N., Kostrzewski, T. M., Stokes, C. L., Griffith, L. G., Hughes, D. J., & Cirit, M. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.237495 · Cited by 119 · see citing works

Modular bioreactor for primary human hepatocyte culture: Medium flow stimulates expression and activity of detoxification genes

Vinci, B., Duret, C., Klieber, S., Gerbal‐Chaloin, S., Cunha, A. S., Laporte, S., Suc, B., Maurel, P., Ahluwalia, A. D., & Daujat‐Chavanieu, M. (2011) · Biotechnology Journal · doi:10.1002/biot.201000326 · Cited by 116 · see citing works

A multicenter assessment of single-cell models aligned to standard measures of cell health for prediction of acute hepatotoxicity

Sison-Young, R. L. C., Lauschke, V. M., Johann, E., Alexandre, E., Anthérieu, S., Aerts, H., Gerets, H. H. J., Labbe, G., Hoët, D., Dorau, M., et al. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1745-4 · Cited by 105 · see citing works

Introducing an automated high content confocal imaging approach for Organs-on-Chips

Peel, S. E., Corrigan, A. M., Ehrhardt, B., Jang, K., Caetano-Pinto, P., Boeckeler, M., Rubins, J. E., Kodella, K. R., Petrópolis, D. B., Ronxhi, J., et al. (2019) · Lab on a Chip · doi:10.1039/c8lc00829a · Cited by 98 · see citing works

On-chip three-dimensional cell culture in phaseguides improves hepatocyte functions in vitro

Jang, M., Neužil, P., Volk, T. J., Manz, A., & Kleber, A. (2015) · Biomicrofluidics · doi:10.1063/1.4922863 · Cited by 98 · see citing works

The Generation, Detection, and Effects of Reactive Drug Metabolites

Stachulski, A. V., Baillie, T. A., Park, B. K., Obach, R. S., Dalvie, D., Williams, D. P., Srivastava, A., Regan, S., Antoine, D. J., Goldring, C. E., et al. (2012) · Medicinal Research Reviews · doi:10.1002/med.21273 · Cited by 88 · see citing works

Mitochondrial Injury Lessons from the Fialuridine Trial

Honkoop, P., Scholte, H. R., de Man, R. A., & Schalm, S. W. (1997) · Drug Safety · doi:10.2165/00002018-199717010-00001 · Cited by 80 · see citing works

Critical differences in toxicity mechanisms in induced pluripotent stem cell-derived hepatocytes, hepatic cell lines and primary hepatocytes

Sjogren, A.-K. M., Liljevald, M., Glinghammar, B., Sagemark, J., Li, X., Jonebring, A., Cotgreave, I. A., Brolén, G., & Andersson, T. B. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1265-z · Cited by 77 · see citing works

Variability of acetaminophen metabolism in Caucasians and Orientals

Patel, M., Tang, B., & KALOW, W. (1992) · Pharmacogenetics · doi:10.1097/00008571-199202000-00007 · Cited by 72 · see citing works

Pharmacokinetics of Chlorzoxazone in Humans

Desiraju, R. K., Renzi, N. L., Nayak, R. K., & Ng, K.-T. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600720905 · Cited by 65 · see citing works

Morphological behaviour and metabolic capacity of cryopreserved human primary hepatocytes cultivated in a perfused multiwell device

Vivarès, A., Salle-Lefort, S., Arabeyre‐Fabre, C., Ngo, R., Pénarier, G., Bremond, M., Moliner, P., Gallas, J., Fabre, G., & Klieber, S. (2014) · Xenobiotica · doi:10.3109/00498254.2014.944612 · Cited by 64 · see citing works

Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man

Dragović, S., Vermeulen, N. P. E., Gerets, H. H. J., Hewitt, P. G., Ingelman‐Sundberg, M., Park, B. K., Juhila, S., Snoeys, J., & Weaver, R. J. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1845-1 · Cited by 57 · see citing works

Cell culture model for acetaminophen-induced hepatocyte death in vivo

Pierce, R. H., Franklin, C. C., Campbell, J. S., Tonge, R. P., Chen, W., Fausto, N., Nelson, S. D., & Bruschi, S. A. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01180-2 · Cited by 56 · see citing works

Innovative organotypic in vitro models for safety assessment: aligning with regulatory requirements and understanding models of the heart, skin, and liver as paradigms

Pridgeon, C. S., Schlott, C., Wong, M. W., Heringa, M. B., Heckel, T., Leedale, J., Launay, L., Gryshkova, V., Przyborski, S. A., Bearon, R. N., et al. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2152-9 · Cited by 50 · see citing works

Novel in vitro and mathematical models for the prediction of chemical toxicity

Williams, D. P., Shipley, R. J., Ellis, M. J., Webb, S., Ward, J., Gardner, I. B., & Creton, S. K. (2012) · Toxicology Research · doi:10.1039/c2tx20031g · Cited by 47 · see citing works

Sleep Mentation in the Elderly

Fein, G., Feinberg, I., Insel, T. R., Antrobus, J. S., Price, L. J., Floyd, T. C., & Nelson, M. A. (1985) · Psychophysiology · doi:10.1111/j.1469-8986.1985.tb01590.x · Cited by 33 · see citing works

Circulating acetaminophen metabolites are toxicokinetic biomarkers of acute liver injury

Vliegenthart, A., Kimmitt, R., Seymour, J., Homer, N., Clarke, J., Eddleston, M., Gray, A., Wood, D., Dargan, P., Cooper, J., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.541 · Cited by 31 · see citing works

Assessment of cryopreserved human hepatocytes as a model system to investigate sulfation and glucuronidation and to evaluate inhibitors of drug conjugation

Riches, Z., Bloomer, J. C., Patel, A. H., Nolan, A., & Coughtrie, M. W. H. (2009) · Xenobiotica · doi:10.1080/00498250902763440 · Cited by 30 · see citing works

Sensitive and specific radioimmunoassay for fialuridine: initial assessment of pharmacokinetics after single oral doses to healthy volunteers

Bowsher, R. R., Compton, J., Kirkwood, J. A., Place, G. D., Jones, C. D., Mabry, T. E., Hyslop, D. L., Hatcher, B. L., & DESANTE, K. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2134 · Cited by 22 · see citing works

The pathogenesis of drug-induced liver injury

Lee, S.-J., Lee, Y. J., & Park, K. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2016.1196133 · Cited by 21 · see citing works

Evaluation of Adverse Drug Properties with Cryopreserved Human Hepatocytes and the Integrated Discrete Multiple Organ Co-culture (IdMOCTM) System

Li, A. P. (2015) · Toxicological Research · doi:10.5487/tr.2015.31.2.137 · Cited by 18 · see citing works

A Novel In Vitro Liver Cell Culture Flow System Allowing Long-Term Metabolism and Hepatotoxicity Studies

Buesch, S., Schroeder, J., Bunger, M. K., D’Souza, T., & Stosik, M. (2018) · Applied In Vitro Toxicology · doi:10.1089/aivt.2018.0009 · Cited by 7 · see citing works

Microfabricated Devices for Studying the Metabolism and Cytotoxicity of Drug Candidates

Whitman, N. A., McIntosh, J. C., Penley, J. B., & Lockett, M. R. (2016) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201017666160301103648 · Cited by 4 · see citing works

Fundamentals and Applications of Photo-Cross-Linking in Bioprinting

Lim, K. S., Galarraga, J. H., Cui, X., Lindberg, G. C. J., Burdick, J. A., & Woodfield, T. B. F. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00812 · Cited by 422 · see citing works

Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology

Ewart, L., Apostolou, A., Briggs, S. A., Carman, C. V., Chaff, J. T., Heng, A. R., Jadalannagari, S., Janardhanan, J., Jang, K.-J., Joshipura, S. R., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00209-1 · Cited by 337 · see citing works

Biology-inspired microphysiological systems to advance medicines for patient benefit and animal welfare

Marx, U. (2020) · ALTEX · doi:10.14573/altex.2001241 · Cited by 258 · see citing works

Engineered Liver-On-A-Chip Platform to Mimic Liver Functions and Its Biomedical Applications: A Review

Deng, J., Wei, W., Chen, Z., Lin, B., Zhao, W., Luo, Y., & Zhang, X. (2019) · Micromachines · doi:10.3390/mi10100676 · Cited by 232 · see citing works

Bioengineered Human Organ-on-Chip Reveals Intestinal Microenvironment and Mechanical Forces Impacting Shigella Infection

Grassart, A., Malardé, V., Gobaa, S., Sartori-Rupp, A., Kerns, J., Karalis, K., Marteyn, B., Sansonetti, P., & Sauvonnet, N. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.08.007 · Cited by 206 · see citing works

A 3D microfluidic liver model for high throughput compound toxicity screening in the OrganoPlate®

Bircsak, K. M., DeBiasio, R., Miedel, M. T., Alsebahi, A., Reddinger, R. M., Saleh, A. D., Shun, T., Vernetti, L. A., & Gough, A. (2021) · Toxicology · doi:10.1016/j.tox.2020.152667 · Cited by 198 · see citing works

Organs-on-chips technologies – A guide from disease models to opportunities for drug development

Monteduro, A. G., Rizzato, S., Caragnano, G., Trapani, A., Giannelli, G., & Maruccio, G. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115271 · Cited by 185 · see citing works

Mechanical Stimulation: A Crucial Element of Organ-on-Chip Models

Thompson, C. L., Fu, S., Heywood, H. K., Knight, M. M., & Thorpe, S. D. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.602646 · Cited by 155 · see citing works

A critical perspective on 3D liver models for drug metabolism and toxicology studies

Serras, A. S., Rodrigues, J. S., Cipriano, M., Rodrigues, A. V., Oliveira, N. G., & Miranda, J. P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.626805 · Cited by 138 · see citing works

Human biomimetic liver microphysiology systems in drug development and precision medicine

Gough, A., Soto-Gutierrez, A., Vernetti, L., Ebrahimkhani, M. R., Stern, A. M., & Taylor, D. L. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00386-1 · Cited by 117 · see citing works

Benzimidazoles in Drug Discovery: A Patent Review

Law, C. S. W., & Yeong, K. Y. (2021) · ChemMedChem · doi:10.1002/cmdc.202100004 · Cited by 93 · see citing works

The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development

Walker, P., Ryder, S., Lavado, A., Dilworth, C., & Riley, R. J. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02763-w · Cited by 93 · see citing works

Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury

Zhou, Y., Shen, J. X., & Lauschke, V. M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01093 · Cited by 85 · see citing works

Primary Human Hepatocyte Spheroid Model as a 3D In Vitro Platform for Metabolism Studies

Kanebratt, K. P., Janefeldt, A., Vilén, L., Vildhede, A., Samuelsson, K., Milton, L., Björkbom, A., Persson, M., Leandersson, C., Andersson, T. B., et al. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.10.043 · Cited by 66 · see citing works

Organ-on-a-Chip Applications in Microfluidic Platforms

An, L., Liu, Y., & Liu, Y. (2025) · Micromachines · doi:10.3390/mi16020201 · Cited by 63 · see citing works

Three-Dimensional Liver Culture Systems to Maintain Primary Hepatic Properties for Toxicological Analysis In Vitro

Kammerer, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910214 · Cited by 59 · see citing works

Functionality of primary hepatic non-parenchymal cells in a 3D spheroid model and contribution to acetaminophen hepatotoxicity

Bell, C. C., Chouhan, B., Andersson, L. C., Andersson, H., Dear, J. W., Williams, D. P., & Söderberg, M. P. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02682-w · Cited by 61 · see citing works

Modelling host–microbiome interactions in organ-on-a-chip platforms

Shin, Y. C., Than, N., Min, S., Shin, W., & Kim, H. J. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00130-9 · Cited by 57 · see citing works

Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development—Current State-of-the-Art and Future Perspectives

Youhanna, S. C., Kemas, A. M., Preiss, L. C., Zhou, Y., Shen, J. X., Cakal, S. D., Paqualini, F. S., Goparaju, S. K., Shafagh, R. Z., Lind, J. U., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000238 · Cited by 57 · see citing works

Three-dimensional liver models: state of the art and their application for hepatotoxicity evaluation

Zhang, X. “., Jiang, T., Chen, D., Wang, Q., & Zhang, L. W. (2020) · Critical Reviews in Toxicology · doi:10.1080/10408444.2020.1756219 · Cited by 53 · see citing works

Current strategies with implementation of three-dimensional cell culture: the challenge of quantification

Temple, J., Velliou, E. G., Shehata, M., Lévy, R., & Gupta, P. (2022) · Interface Focus · doi:10.1098/rsfs.2022.0019 · Cited by 49 · see citing works

Organotypic and Microphysiological Models of Liver, Gut, and Kidney for Studies of Drug Metabolism, Pharmacokinetics, and Toxicity

Shen, J. X., Youhanna, S. C., Shafagh, R. Z., Kele, J., & Lauschke, V. M. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00245 · Cited by 48 · see citing works

Photocrosslinkable liver extracellular matrix hydrogels for the generation of 3D liver microenvironment models

Ravichandran, A., Murekatete, B., Moedder, D., Meinert, C., & Bray, L. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-94990-z · Cited by 49 · see citing works

Liver microphysiological platforms for drug metabolism applications

Kulsharova, G., & Kurmangaliyeva, A. (2021) · Cell Proliferation · doi:10.1111/cpr.13099 · Cited by 48 · see citing works

Bioprinting of Human Liver‐Derived Epithelial Organoids for Toxicity Studies

Bouwmeester, M., Bernal, P. N., Oosterhoff, L. A., van Wolferen, M. E., Lehmann, V., Vermaas, M., Buchholz, M., Peiffer, Q. C., Malda, J., van der Laan, L. J. W., et al. (2021) · Macromolecular Bioscience · doi:10.1002/mabi.202100327 · Cited by 49 · see citing works

Fabrication of Cell Spheroids for 3D Cell Culture and Biomedical Applications

Park, S. Y., Hong, H. J., & Lee, H. J. (2022) · BioChip Journal · doi:10.1007/s13206-022-00086-9 · Cited by 46 · see citing works

Adaptation of the in vitro micronucleus assay for genotoxicity testing using 3D liver models supporting longer-term exposure durations

Conway, G. E., Shah, U.-K., Llewellyn, S. V., Červená, T., Evans, S. J., Ali, A., Jenkins, G. J. S., Clift, M. J. D., & Doak, S. H. (2020) · Mutagenesis · doi:10.1093/mutage/geaa018 · Cited by 46 · see citing works

Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery

Fu, J., Qiu, H., & Tan, C. S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041300 · Cited by 42 · see citing works

Usability of Polydimethylsiloxane-Based Microfluidic Devices in Pharmaceutical Research Using Human Hepatocytes

Deguchi, S., Tsuda, M., Kosugi, K., Sakamoto, A., Mimura, N., Negoro, R., Sano, E., Nobe, T., Maeda, K., Kusuhara, H., et al. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00642 · Cited by 41 · see citing works

Advances of dual-organ and multi-organ systems for gut, lung, skin and liver models in absorption and metabolism studies

Brandauer, K., Schweinitzer, S., Lorenz, A., Krauß, J., Schobesberger, S., Frauenlob, M., & Ertl, P. (2025) · Lab on a Chip · doi:10.1039/d4lc01011f · Cited by 39 · see citing works

Microscale Collagen and Fibroblast Interactions Enhance Primary Human Hepatocyte Functions in Three-Dimensional Models

Kukla, D. A., Crampton, A. L., Wood, D. K., & Khetani, S. R. (2020) · Gene Expression · doi:10.3727/105221620x15868728381608 · Cited by 38 · see citing works

Qualifying a human Liver-Chip for predictive toxicology: Performance assessment and economic implicationsPreprint

Ewart, L. C., Apostolou, A. P., Briggs, S. A., Carman, C. V., Chaff, J. T., Heng, A. R., Jadalannagari, S., Janardhanan, J., Jang, K., Joshipura, S. R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.14.472674 · Cited by 36 · see citing works

Recent advances in liver‐on‐chips: Design, fabrication, and applications

Qiu, L., Kong, B., Kong, T., & Wang, H. (2023) · Smart Medicine · doi:10.1002/smmd.20220010 · Cited by 37 · see citing works

Liver-on-chips for drug discovery and development

Mehta, V., Karnam, G., & Madgula, V. L. M. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101143 · Cited by 40 · see citing works

Bioengineered Human Organ-on-Chip Reveals Intestinal Microenvironment and Mechanical Forces Impacting Shigella Infection

Grassart, A., Malardé, V., Gobaa, S., Sartori-Rupp, A., Kerns, J., Karalis, K. P., Marteyn, B., Sansonetti, P. J., & Sauvonnet, N. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.09.007 · Cited by 32 · see citing works

Progress towards 3D bioprinting of tissue models for advanced drug screening: In vitro evaluation of drug toxicity and drug metabolism

Pagnotta, G., Kalia, S., Lisa, L. D., Cicero, A. F. G., Borghi, C., & Focarete, M. L. (2022) · Bioprinting · doi:10.1016/j.bprint.2022.e00218 · Cited by 30 · see citing works

Development of Liver-on-Chip Integrating a Hydroscaffold Mimicking the Liver’s Extracellular Matrix

Messelmani, T., Goff, A. L., Souguir, Z., Maes, V., Roudaut, M., Vandenhaute, E., Maubon, N., Legallais, C., Leclerc, É., & Jellali, R. (2022) · Bioengineering · doi:10.3390/bioengineering9090443 · Cited by 29 · see citing works

The application of omics-based human liver platforms for investigating the mechanism of drug-induced hepatotoxicity in vitro

Jiang, J., Pieterman, C., Ertaylan, G., Peeters, R., & de Kok, T. M. C. M. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02585-5 · Cited by 31 · see citing works

Microfluidic human physiomimetic liver model as a screening platform for drug induced liver injury

Dey, S., Bhat, A., Janani, G., Shandilya, V., Gupta, R., & Mandal, B. B. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122627 · Cited by 28 · see citing works

Evaluation of a Three-Dimensional Primary Human Hepatocyte Spheroid Model: Adoption and Industrialization for the Enhanced Detection of Drug-Induced Liver Injury

Schofield, C. A., Walker, T. M., Taylor, M. A., Patel, M., Vlachou, D. F., Macina, J. M., Vidgeon-Hart, M., Williams, A., McGill, P., Newman, C. F., et al. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.1c00227 · Cited by 28 · see citing works

Conditions for maintenance of hepatocyte differentiation and function in 3D cultures

Handin, N., Mickols, E., Ölander, M., Rudfeldt, J., Blom, K., Nyberg, F., Senkowski, W., Urdzik, J., Maturi, V., Fryknäs, M., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103235 · Cited by 27 · see citing works

State-of-the-art advancements in Liver-on-a-chip (LOC): Integrated biosensors for LOC

Liu, M., Xiang, Y., Yang, Y., Long, X., Xiao, Z., Nan, Y., Jiang, Y., Qiu, Y., Huang, Q., & Ai, K. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114758 · Cited by 27 · see citing works

Simulation and modeling of physiological processes of vital organs in organ-on-a-chip biosystem

Seidi, S., Eftekhari, A., Khusro, A., Heris, R. S., Sahibzada, M. U. K., & Gajdács, M. (2021) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2021.101710 · Cited by 26 · see citing works

Evaluation of the utility of the Beta Human Liver Emulation System (BHLES) for CFSAN's regulatory toxicology program

Eckstrum, K., Striz, A., Ferguson, M. S., Zhao, Y., & Sprando, R. L. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.112828 · Cited by 26 · see citing works

Setup of human liver-chips integrating 3D models, microwells and a standardized microfluidic platform as proof-of-concept study to support drug evaluation

Cox, B., Barton, P., Class, R., Coxhead, H., Delatour, C., Gillent, E., Henshall, J., Isin, E. M., King, L. M., & Valentin, J. (2022) · Biomaterials and Biosystems · doi:10.1016/j.bbiosy.2022.100054 · Cited by 27 · see citing works

Extrusion-Based Bioprinting of Multilayered Nanocellulose Constructs for Cell Cultivation Using In Situ Freezing and Preprint CaCl2 Cross-Linking

Rasheed, A., Azizi, L., Turkki, P., Janka, M., Hytönen, V. P., & Tuukkanen, S. (2020) · ACS Omega · doi:10.1021/acsomega.0c05036 · Cited by 25 · see citing works

Non-human primates in the PKPD evaluation of biologics: Needs and options to reduce, refine, and replace. A BioSafe White Paper

Ménochet, K., Yu, H., Wang, B., Tibbitts, J., Hsu, C., Kamath, A. V., Richter, W. F., & Baumann, A. (2022) · mAbs · doi:10.1080/19420862.2022.2145997 · Cited by 25 · see citing works

Intermittent Starvation Extends the Functional Lifetime of Primary Human Hepatocyte Cultures

Davidson, M. D., & Khetani, S. R. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa003 · Cited by 22 · see citing works

Toward continuous monitoring systems: emerging trends of on-chip sensors in organ-on-a-chip

Ling, S., Xu, C., Jiang, Y., Xu, F., Jin, H., Chen, H. H., Chen, S., Ding, Z., & Sun, D. (2026) · Microsystems & Nanoengineering · doi:10.1038/s41378-025-01142-8 · Cited by 24 · see citing works

Transporter–enzyme interplay and the hepatic drug clearance: what have we learned so far?

Alluri, R. V., Li, R., & Varma, M. V. S. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1749595 · Cited by 21 · see citing works

In vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation

Mirahmad, M., Sabourian, R., Mahdavi, M. R., Larijani, B. A., & Safavi, M. (2022) · Drug Metabolism Reviews · doi:10.1080/03602532.2022.2064487 · Cited by 20 · see citing works

Complex in vitro models positioned for impact to drug testing in pharma: a review

Kang, S., Chen, E. C., Cifuentes, H., Co, J. Y., Cole, G., Graham, J. C., Hsia, I., Kiyota, T., Klein, J. A., Kroll, K. T., et al. (2024) · Biofabrication · doi:10.1088/1758-5090/ad6933 · Cited by 21 · see citing works

HepaChip-MP – a twenty-four chamber microplate for a continuously perfused liver coculture model

Busche, M., Tomilova, O., Schütte, J., Werner, S., Beer, M., Groll, N., Hagmeyer, B., Pawlak, M., Jones, P. D., Schmees, C., et al. (2020) · Lab on a Chip · doi:10.1039/d0lc00357c · Cited by 19 · see citing works

New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now?

Shrimali, S., Chen, M., Li, D., & Tong, W. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104452 · Cited by 17 · see citing works

Unusual Biotransformation Reactions of Drugs and Drug Candidates

Isin, E. M. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000744 · Cited by 16 · see citing works

Taking the leap toward human-specific nonanimal methodologies: The need for harmonizing global policies for microphysiological systems

Parvatam, S., Pamies, D., Pistollato, F., Beken, S., Mariappan, I., Roth, A. B., Piergiovanni, M., Maisonneuve, B. G. C., Ewart, L. C., Majumder, A., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.11.008 · Cited by 17 · see citing works

Generation of Tetrafluoroethylene–Propylene Elastomer-Based Microfluidic Devices for Drug Toxicity and Metabolism Studies

Sano, E., Deguchi, S., Matsuoka, N., Tsuda, M., Wang, M., Kosugi, K., Mori, C., Yagi, K., Wada, A., Yamasaki, S., et al. (2021) · ACS Omega · doi:10.1021/acsomega.1c03719 · Cited by 15 · see citing works

Reconstituted Human Organ Models as a Translational Tool for Human Organ Response: Definition, Expectations, Cases, and Strategies for Implementation in Drug Discovery and Development

Tetsuka, K., Ohbuchi, M., Kawabe, T., Goto, T., Kiyonaga, F., Takama, K., Yamazaki, S., & Fujimori, A. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-01070 · Cited by 13 · see citing works

Challenges in the Development and Application of Organ-on-Chips for Intranasal Drug Delivery Studies

Khan, M. U., Cai, X., Shen, Z., Mekonnen, T. T., Kourmatzis, A., Cheng, S., & Gholizadeh, H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051557 · Cited by 13 · see citing works

Microphysiological systems as an emerging in vitro approach for the evaluation of drug absorption, distribution, metabolism, and excretion and toxicity

Shrimali, S., Li, D., Knox, B., Tong, W., & Ning, B. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100187 · Cited by 13 · see citing works

Organ-on-a-Chip

Maschmeyer, I., & Kakava, S. (2020) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2020_135 · Cited by 12 · see citing works

Constructing biomimetic microenvironments for liver regeneration

(2025) · doi:10.1186/s12951-025-03729-9 · Cited by 11 · see citing works

Three-Dimensional Spheroids for Cancer Research

Tutty, M. A., & Prina‐Mello, A. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3056-3_3 · Cited by 10 · see citing works

3D In Vitro Human Organ Mimicry Devices for Drug Discovery, Development, and Assessment

Rodríguez‐García, A., Oliva, J., Flores, C., & Hosseini, S. (2020) · Advances in Polymer Technology · doi:10.1155/2020/6187048 · Cited by 10 · see citing works

A scalable human liver-on-a-chip platform for predictive safety assessment

Kulkarni, G., Chen, L., Sang, J., Seo, J. H., Grall, R., Wang, Y., Gilbride, P., Yuan, Y., Albaum-Getzen, M., McCormack, J., et al. (2025) · Toxicology · doi:10.1016/j.tox.2025.154378 · Cited by 9 · see citing works

From fatty hepatocytes to impaired bile flow: Matching model systems for liver biology and disease

Kunst, R. F., Niemeijer, M., van der Laan, L. J. W., Spee, B., & van de Graaf, S. F. J. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114173 · Cited by 9 · see citing works

Application of Micro-Engineered Kidney, Liver, and Respiratory System Models to Accelerate Preclinical Drug Testing and Development

Gholizadeh, H., Cheng, S., Kourmatzis, A., Xing, H., Traini, D., Young, P. M., & Ong, H. X. (2022) · Bioengineering · doi:10.3390/bioengineering9040150 · Cited by 9 · see citing works

Sensors and Biosensors in Organs-on-a-Chip Platforms

López‐Muñoz, G. A., Mughal, S., & Ramón‐Azcón, J. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-04039-9_3 · Cited by 9 · see citing works

Synthesis of novel carboxamide- and carbohydrazide-benzimidazoles as selective butyrylcholinesterase inhibitors

Öztürk, Ö., Farouk, F. M., Ooi, L., Law, C. S. W., Muhammed, M. T., Aki, E., & Yeong, K. Y. (2022) · Molecular Diversity · doi:10.1007/s11030-022-10476-8 · Cited by 8 · see citing works

Long-Term Engineered Cultures of Primary Mouse Hepatocytes for Strain and Species Comparison Studies During Drug Development

Ware, B. R., Brown, G. E., Soldatow, V. Y., LeCluyse, E. L., & Khetani, S. R. (2019) · Gene Expression · doi:10.3727/105221619x15638857793317 · Cited by 8 · see citing works

Spatial patterning strategies for liver tissue engineering: Biofabrication technologies and applications

Nah, H., Michell, A. R., Rogy, K. M., Lally, O. J., & Khetani, S. R. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115737 · Cited by 7 · see citing works

The Promise of Animal Testing Alternatives at the U.S. Food and Drug Administration and National Institutes of Health

Tieghi, R. S., Høeg, T. B., Makary, M. A., & Kleinstreuer, N. (2025) · NEJM AI · doi:10.1056/aipc2500587 · Cited by 7 · see citing works

Proteomic profiling of murine biliary-derived hepatic organoids and their capacity for drug disposition, bioactivation and detoxification

Howell, L., Jenkins, R. E., Lynch, S., Duckworth, C., Kevin Park, B., & Goldring, C. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03075-3 · Cited by 7 · see citing works

A Step Forward in the Characterization of Primary Brown Trout Hepatocytic Spheroids as Experimental Models

Alves, R. F., Lopes, C. C. C., Rocha, E., & Madureira, T. V. (2023) · Animals · doi:10.3390/ani13142277 · Cited by 7 · see citing works

Human-Induced Pluripotent Stem Cell-Derived Hepatocytes and their Culturing Methods to Maintain Liver Functions for Pharmacokinetics and Safety Evaluation of Pharmaceuticals

Inoue, T., Iwazaki, N., Araki, T., & Hitotsumachi, H. (2020) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666200131123524 · Cited by 7 · see citing works

Hepatotoxicity evaluation of cannabidiol, cannabinol, cannabichromene and cannabigerol using a human quad culture liver chip

Larson, J. D., Jadalannagari, S., Chaff, J. T., Velez, J., Sliz, J. D., Ewart, L. C., Webster, D., & Hu, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-12846-2 · Cited by 6 · see citing works

Comparative Analysis of Species-Specific Hepatocyte Function and Drug Effects in a Liver Microphysiological System PhysioMimix LC12 and 96-Well Plates

Negi, C. K., Sakolish, C., Tsai, H.-H. D., Nitsche, K. S., Gang, H., Bajaj, P., Ferguson, S., Stanko, J. P., Hewitt, P. G., Kukla, D. A., et al. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00554 · Cited by 6 · see citing works

Dual-emission red carbon dots for ATP real-time monitoring and quantification to reveal drug and cancer effects on lysosomes

Hu, J., Wang, T., Xu, J., Hai, J., Ji, Y., & Li, R. (2024) · Talanta · doi:10.1016/j.talanta.2024.126671 · Cited by 6 · see citing works

Towards More Human and Humane Testing: The Role of the Device Supplier Industry

Cuanalo-Contreras, K., & Benkmann, D. (2022) · Alternatives to Laboratory Animals · doi:10.1177/02611929211073132 · Cited by 6 · see citing works

Estrogenic Responsiveness of Brown Trout Primary Hepatocyte Spheroids to Environmental Levels of 17α-Ethinylestradiol

Alves, R. F., Lopes, C. C. C., Rocha, E., & Madureira, T. V. (2024) · Journal of Xenobiotics · doi:10.3390/jox14030060 · Cited by 5 · see citing works

Human serum albumin-based cryogels as a biomimetic platform for 3D co-culture and drug-induced liver injury prediction

Duan, K., Hu, J., Zhao, Y., Lin, M., Xu, M., Li, T., & Lee, B. H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146376 · Cited by 5 · see citing works

Experimental Models for Studying Structural and Functional State of the Pathological Liver (Review)

Krylov, D. P., Rodimova, S. A., Karabut, M. M., & Kuznetsova, D. S. (2023) · Современные технологии в медицине · doi:10.17691/stm2023.15.4.06 · Cited by 5 · see citing works

3D microscaffolds with triple-marker sensitive nanoprobes for studying fatty liver disease in vitro

Rainu, S. K., & Singh, N. (2024) · Nanoscale · doi:10.1039/d4nr00434e · Cited by 4 · see citing works

Water-in-oil microcompartments for the study of biomimetic drug metabolism

Dai, Y., Yang, Y., Liu, B., & Qiao, L. (2020) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2020.02.096 · Cited by 4 · see citing works

Physiologically relevant microsystems to study viral infection in the human liver

McDuffie, D., Barr, D., Agarwal, A., & Thomas, E. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.999366 · Cited by 4 · see citing works

Development of a complex 3D in vitro alternative model to evaluate the safety of advanced materials

Tutty, M. A., Simone, T., & Prina‐Mello, A. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117520 · Cited by 3 · see citing works

Changes in cultivation parameters impact cytochrome P450 gene transcription in HepaRG cells: implications for in vitro toxicological assessments

Jochum, K., Städele, V., & Marx‐Stoelting, P. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1690384 · Cited by 3 · see citing works

Advanced human liver models for the assessment of drug-induced liver injury

Mun, S. J., Lee, J., Shin, Y., & Son, M. J. (2022) · Organoid · doi:10.51335/organoid.2022.2.e17 · Cited by 3 · see citing works

Recent advances in tumors-on-chips

Dogan, E., Salemizadehparizi, F., Çeçen, B., & Miri, A. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85671-3.00006-3 · Cited by 3 · see citing works

A robust dynamic 3D liver spheroid platform for (sub)chronic toxicity assessment: Metabolic characterization of HepG2 spheroids as a case study

Brenner, D., Bergo, A. M., Řehůřková, E., Havlík, J., Babica, P., & Sovadinová, I. (2026) · Toxicology · doi:10.1016/j.tox.2026.154538 · Cited by 2 · see citing works

Induction of CYP450 by illicit drugs: Studies using an in vitro 3D spheroidal model in comparison to animals

Duan, S., Jia, Y., Zhu, Z., Wang, L., Xu, P., Wang, Y., Di, B., & Hu, C. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2022.07.815 · Cited by 2 · see citing works

Proteomics informed investigation of human hepatocytes and liver tissue

Handin, N. (2021) · Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy · doi:10.33063/diva-446954 · Cited by 2 · see citing works

Recent advances in multicellular human liver models

Mun, S. J., Lee, J., Shin, Y., Eun, V., Ji, Y., & Son, M. J. (2022) · Organoid · doi:10.51335/organoid.2022.2.e26 · Cited by 1 · see citing works

Disproportionate drug metabolites: challenges and solutions

Prakash, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-817134-9.00017-9 · Cited by 1 · see citing works

Liver Microphysiological System for Drug-induced Liver Injury (DILI) Evaluation based on Kinetic-pump Integrated Microfluidic Plate (KIM-Plate)

Shinha, K., Nakamura, H., Nishikawa, M., Sakai, Y., & Kimura, H. (2025) · IEEJ Transactions on Sensors and Micromachines · doi:10.1541/ieejsmas.145.46 · Cited by 1 · see citing works

Navigating Drug Dynamics: Unleashing On-Chip Pharmacokinetics and Pharmacodynamics

Das, A. K., Mutukuri, R., Chowdhury, N., Paul, D., & Nanjappan, S. K. (2025) · Drug Metabolism and Bioanalysis Letters · doi:10.2174/0118723128377867250225073257 · Cited by 1 · see citing works

Use of new approach methodology for hepatic safety assessment of covalent inhibitor drug candidates

Amberntsson, S., Foster, A. J., Chouhan, B., Wilkinson, S. D., Harlfinger, S., Smith, G., Kettle, J. G., Niedbala, M. J., Kavanagh, S. L., & Williams, D. P. (2025) · Toxicology Research · doi:10.1093/toxres/tfaf054 · Cited by 1 · see citing works

Recent advances of microfluidic organ-on-a-chip monitoring strategies

Ebrahimi, A., Benzait, Z., Tomsuk, Ö., Özel, C., Tüfekçioğlu, E., Dordinejad, G. G., Didarian, R., Ghorbanpoor, H., Güzel, F. D., & Avcı, H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21519-3.00029-7 · Cited by 1 · see citing works

Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug discovery

Hellgren, J., Chouhan, B., Uatay, A., Elgendy, R., Lindgren, J., Toki, N., Bonetti, A., Chaudhari, A., Pryde, K. R., Andersson, P. U., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-01306-7 · Cited by 1 · see citing works

Development of a primary hepatocyte-based preclinical spheroid model system for the analysis of Phase I and Phase II enzyme activity in vitro

Arai, K., Fukuhara-Obonai, K., Ishimaru, S., Kojima, N., Mir, T. A., Kitsuka, T., & Hosaka, M. (2026) · Engineered Regeneration · doi:10.1016/j.engreg.2026.01.001 · Cited by 1 · see citing works

Mechanistically resolved prediction of compound hepatotoxicity using primary human liver spheroids—Application to recent real-world cases

Li, Y., Sheng, H., Zhou, T., Xing, C., Kukasch, M., Shao, S., Youhanna, S. C., Vorrink, S. U., Liang, Y., Nies, A. T., et al. (2026) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2026.100346 · Cited by 3 · see citing works

Setup of human liver-chips integrating 3D models, microwells and a standardized microfluidic platform as proof-of-concept study to support drug evaluation

Cox, B., Barton, P., Class, R., Coxhead, H., Delatour, C., Gillent, E., Henshall, J., Isin, E. M., King, L. M., & Valentin, J. (2022) · Biomaterials and Biosystems · doi:10.1016/j.bbiosy.2022.100054 · Cited by 27 · see citing works

Human-Relevant 3D In Vitro Liver Spheroids for Preclinical Hepatotoxicity PredictionPreprint

Subia, B., Patel, H., Nathwani, S., Jain, M., & Viswanathan, K. (2026) · Research Square · doi:10.21203/rs.3.rs-10560086/v1

In Vitro and in Vivo Assessments of Drug-induced Hepatotoxicity and Drug Metabolism in Humans

Sanoh, S. (2015) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.15-00200 · Cited by 3 · see citing works

LP-43 Comparing sensitivity of primary hepatocyte and hepatocyte-like spheroids toward drug induced toxicity

Pacsuta, J., Mártonné-Tóth, B., Kis, E.-É., Jemnitz, K., & Gáborik, Z. (2025) · Toxicology Letters · doi:10.1016/j.toxlet.2025.07.1057